Artemisia inhibits viral activity

Extracts from Artemisia annua have shown antiviral activity against SARS-CoV-2 in lab studies and are now in human clinical trials testing against COVID-19
   
Extracts from Artemisia have been studied as treatment for HIV infections, obesity, pollen allergies, glucose intolerance and the treatment of some cancers; it has been a treatment for malaria for 30 years

The plant has high levels of zinc, gallium and selenium, all of which have known antiviral and anti-inflammatory properties. Extracts from Artemisia were also tested in 2003 after the SARS outbreak with positive outcome in the lab
   
In August 2021, the WHO included a derivative called artesunate in the next phase of the Solidarity trial testing drugs against COVID-19 but, to date, there is no definitive evidence that products from Artemisia are effective against COVID-19

Read the full analysis by Dr. Mercola

 

 

George W. Bush: The terrorists want to change our lifestyle